Apollo Hospitals Enterprise Limited (NSE: APOLLOHOSP, BSE: 508869) is a Chennai, Tamil Nadu-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹1,13,446 Cr, it ranks #88 by market cap among the 6,137 Indian listed companies on FinBizNet, and #1 of 42 in Hospitals and Healthcare Centers. At ₹7,730.00 (as of 25 Oct 2026), the share price is 14.8% below its 52-week high of ₹9,070.50 and 15.4% above its 52-week low of ₹6,696.50. The share price is down 1.3% over one year and down 12.2% over three months.
| Current Price | ₹7,730.00 |
|---|---|
| Market Cap | ₹1,13,446 Cr |
| NSE Symbol | APOLLOHOSP |
| BSE Code | 508869 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 57 |
| Return on Equity | 21.50% |
| Return on Assets | 8.47% |
| 52-Week Range | ₹6,696.50 – ₹9,070.50 |
| 1-Year Price Change | -1.3% |
| 3-Month Price Change | -12.2% |
| Beta (1Y) | 0.3 |
| Dividend Yield | 0.26% |
| Headquarters | Chennai, Tamil Nadu |
| Website | www.apollohospitals.com |
| Revenue | ₹7,044 Cr |
|---|---|
| Net Profit | ₹597 Cr |
| Net Margin | 8.5% |
| EPS (Basic) | ₹40.39 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company’s healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities. It offers services in cardiac sciences, oncology, neurosciences, gastroenterology, orthopedics, urology, organ transplantation, pulmonology, obstetrics and gynecology, internal medicine, vascular surgery, pediatrics, cosmetology, emergency medicine, bariatric surgery, general surgery, colorectal surgery, dentistry, nephrology, dermatology, endocrinology, preventive medicine, interventional radiology, ophthalmology, and integrative medicine, as well as robotic surgery and genomics. The company also provides project consultancy, medical educational institutes, Medvarsity for e-learning, and research services, as well as acts as an agent f
1. Healthcare Services-This segment operates hospitals and hospital based pharmacies. 2. Apollo Digital 24/7 Business-This segment operates pharmacy retail outlets. 3. Clinics-This segment operates clinics. 4. Others-This segment holds investments and fixed deposits.
1. Healthcare Services-50.5% 2. Retail Health & Diagnostics-7.4% 3. Digital Health & Pharmacy Distribution-42.8% 4. Others-0%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹1,13,446 Cr | 57 | 21.50% | ₹7,044 Cr | -1.3% |
| Manipal Health Enterprises Ltd | ₹84,500 Cr | 82.1 | — | ₹3,091 Cr | — |
| Max Healthcare Institute Ltd | ₹82,242 Cr | 56.3 | 14.33% | ₹2,366 Cr | -30.7% |
| Aster Dm Healthcare Limited (Asterdm) | ₹58,702 Cr | 88.7 | 10.07% | ₹1,311 Cr | -7.8% |
| Fortis Healthcare Ltd. | ₹55,603 Cr | 53.3 | 11.01% | ₹2,545 Cr | -34.9% |
| Global Health Ltd (Medanta) | ₹33,340 Cr | 60 | 15.03% | ₹1,304 Cr | -15.1% |
| Krishna Institute Of Medical Science (KIMS) | ₹27,434 Cr | 112.5 | 9.72% | ₹1,180 Cr | -9.4% |
| Dr. Agarwal's Health Care Limited | ₹14,767 Cr | 112 | 8.31% | ₹614 Cr | -9.3% |
| Rainbow Children'S Medicare Limited | ₹12,685 Cr | 45.1 | 17.94% | ₹470 Cr | -11.6% |
Listed by market capitalisation. Ratios are shown for context only.
Apollo Hospitals Enterprise Limited is trading at ₹7,730.00, with a market capitalisation of ₹1,13,446 Cr.
Apollo Hospitals Enterprise Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Apollo Hospitals Enterprise Limited has a P/E of 57 and a return on equity of 21.50%.
Apollo Hospitals Enterprise Limited is listed on the NSE under the symbol APOLLOHOSP and on the BSE under the scrip code 508869.
Apollo Hospitals Enterprise Limited's share price is down 1.3% over one year and down 12.2% over three months. Its 52-week range is ₹6,696.50 to ₹9,070.50.
In Q1 FY27, Apollo Hospitals Enterprise Limited reported revenue of ₹7,044 Cr and net profit of ₹597 Cr, with basic EPS of ₹40.39 (consolidated, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.